It was reported that the stent fractured and occluded.The patient experienced pain due to this.A 6x120 cm eluvia drug-eluting vascular stent system was selected for the patient procedure on (b)(6) 2020.The patient had peripheral artery disease.The lesion was moderately tortuous, 100% stenosed, and severely calcified.The treatment site was a chronic total occlusion at the left superficial femoral artery and popliteal artery.The stent was placed from "p1 to p2." on (b)(6) 2021, the patient presented to the physician due to pain in the lower limb.When examined, the distal side (p2 part) of the eluvia was separated.Follow-up contrast was performed and found an occlusion within the eluvia.Collateral circulation was noted, so below the knee circulation has persisted due to the blood flow from the collateral circulation.A high fracture tolerance of the eluvia stent was found, and it was stated that the location where the device was placed (p2) was not good.No additional interventions or adverse effects were reported.A bypass surgery will be scheduled sometime in the future; it has not yet been scheduled.
|